Pascal Grenier
34Patents
9h-index
24Co-inventors
75Inventor score
Filing activity: Dec 16, 1992 → Mar 17, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5413774A | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof | Human Necessities | 185 | Expired |
| US5578292A | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 108 | Expired |
| US6027748A | Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption | Human Necessities | 107 | Expired |
| US6149940A | Tablet with controlled release of alfuzosine chlorhydrate | Human Necessities | 100 | Expired |
| US6221395A | Controlled release pharmaceutical tablets containing an active principle of low water solubility | Human Necessities | 41 | Expired |
| US8927028B2 | Pharmaceutical composition containing coated, floating particles | Human Necessities | 25 | Active |
| US6136293A | Stable microbubbles suspensions containing saturated lamellar phospholipids | Human Necessities | 21 | Expired |
| US8394407B2 | Delayed release tablet with defined core geometry | Human Necessities | 13 | Active |
| US8168218B2 | Delayed release tablet with defined core geometry | Human Necessities | 11 | Active |
| US8460706B2 | Hydrophilic/lipophilic polymeric matrix dosage formulation | Human Necessities | 8 | Active |
| US6485705B1 | Mixable combination for generating a suspension of stable microbubbles for ultrasonic imaging | Human Necessities | 8 | Expired |
| US6613306B1 | Ultrasound contrast agents and methods of making and using them | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7838028B2 | Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of same | Human Necessities | 6 | Expired |
| US8309124B2 | Delayed release tablet with defined core geometry | Human Necessities | 5 | Active |
| US8003690B2 | Topical nanoparticulate spironolactone formulation | Human Necessities | 5 | Active |
| US7083778B2 | Ultrasound contrast agents and methods of making and using them | Human Necessities | 4 | Expired |
| US6881397B2 | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof | Human Necessities | 3 | Expired |
| US9622980B2 | Controlled release compositions | Emerging Cross-Sectional Technologies | 3 | Active |
| US6592846B1 | Long-lasting aqueous dispersions or suspensions of pressure resistant gas-filled microvesicles and methods for thereof preparation thereof | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6896875B2 | Mixable combination for generating a suspension of stable microbubbles for ultrasonic imaging | Human Necessities | 2 | Expired |
| US6585955B1 | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9314430B2 | Floating gastric retentive dosage form | Human Necessities | 1 | Active |
| US9101544B2 | Controlled release nisoldipine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9186332B2 | Delayed release tablet with defined core geometry | Human Necessities | 1 | Active |
| US9040085B2 | Delayed release tablet with defined core geometry | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.